www.Stylo4Life.com

www.Stylo4Life.com

www.Stylo4Life.com

1. Bock K Transfer Factor: Immune System Modulators Autism/Asperger's Digest-2004. 2.. Moss RW Cancer and complementary and alternative medicine in Italy: personal observations and historical considerations. Integr Cancer Ther-2004. 3(2);173-88 3.. Singh VK Autoimmunity as Basis of Therapy for Autism In: Center for Autistic Spectrum Disorders Conference. Dallas, TX. -2003. 4.. Kidd PM Autism, an extreme challenge to integrative medicine. Part 2: medical management. Altern Med Rev-2002. 7(6);472-99 5.. Molife R, Hancock BW Adjuvant therapy of malignant melanoma. Crit Rev Oncol Hematol-2002. 44(1);81-102 6.. [No Author(s)] Jarrow formulas: "colostrum specific" for cryptospordium. Posit Health News-2001. 7.. [No Author(s)] Transfer factor. Posit Health News-2001. 8.. Sosa Vazquez M, et al. [New concepts about atopic dermatitis] Rev Alerg Mex-2001. 48(1);15-24 9.. Bock SJ Transfer Factor and its Clinical Applications Rhinebeck Health Center-2000. 10.. Liubchenko TA, et al. [The biological activity of the transfer factor induced by bacterial antigens] Mikrobiol Z-1998. 59(5);83-100 11.. Salazar Villa RM, Mejia Ortega J [Use of transfer++factor in allergic bronchial asthma] Rev Alerg-1997. 40(2);42-5 12.. Bang D Treatment of Behcet's disease. Yonsei Med J-1997. 38(6);401-10 13.. Dwyer JM Transfer factor in the age of molecular biology: a review. Biotherapy-1996. 9(1-3);7-11 14.. Kirkpatrick CH Activities and characteristics of transfer factors. Biotherapy-1996. 9(1-3);13-6 15.. Levine PH The use of transfer factors in chronic fatigue syndrome: prospects and problems. Biotherapy-1996. 9(1-3);77-9 16.. Viza D AIDS and transfer factor: myths, certainties and realities. Biotherapy-1996. 9(1-3);17-26 17.. Katoch K Immunotherapy of leprosy. Indian J Lepr-1996. 68(4);349-61 18.. Hicks P, et al. Azithromycin therapy for Cryptosporidium parvum infection in four children infected with human immunodeficiency virus. J Pediatr-1996. 129(2);297-300 19.. Ritchie DJ, Becker ES Update on the management of intestinal cryptosporidiosis in AIDS. Ann Pharmacother-1994. 28(6);767-78 20.. Kirkpatrick CH Structural nature and functions of transfer factors. Ann N Y Acad Sci-1993. 685(0);362-8 21.. Berthon P, Salmon H Immunological Factors in Mammary Secretions. Biologie de la Lactation. Institut National de la Recherche Agronomique. Versailles, France-1993. 22.. Hassner A, Adelman DC Biologic response modifiers in primary immunodeficiency disorders. Ann Intern Med-1991. 115(4);294-307 23.. Dwyer JM The rise and fall and rise again of transfer factor. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991. 24.. Pekarek J, et al. The clinical use of specific transfer factors. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991. 25.. Woodfield DG, et al. Transfer factor - Preparation, quality control and clinical use in New Zealand. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991. 26.. Crusinberry R, Williams RD Immunotherapy of renal cell cancer. Semin Surg Oncol-1991. 7(4);221-9 27.. Hadden JW Immunotherapy of human immunodeficiency virus infection. Trends Pharmacol Sci-1991. 12(3);107-11. 28.. Gottlieb AA, Gottlieb MS Development of immunomodulators for treatment of HIV infection. Lymphology-1990. 23(2);98-101 29.. Smogorzewska E [Transfer of delayed type hypersensitivity in guinea pigs] Probl Med Wieku Rozwoj-1990. 16(0);167-88 30.. Kirkpatrick CH Biological response modifiers. Interferons, interleukins, and transfer factor. Ann Allergy-1989. 62(3);170-6 31.. Fudenberg HH, Fudenberg HH Transfer factor: Past, Present and Future. In: Research and Application of TF and DLE. Baolai H, Ruzhang W, Zhaofen Z, Eds. Xue Yuan Press, Beijing-1989. 32.. Soave R Clinical Cryptosporidiosis in Man. Proc 1st Int work. Edinburgh Animal Diseases Research Assoc.-1989. 33.. Kirkpatrick CH Transfer factor. J Allergy Clin Immunol-1988. 81(5 Pt 1);803-13 34.. Steele RW, Charlton RK Immune modulators as antiviral agents. Clin Lab Med-1987. 7(4);911-24 35.. Purdy BD, Plaisance KI Current concepts in clinical therapeutics: immunologic treatment of human immunodeficiency virus infections. Clin Pharm-1987. 6(11);851-65 36.. Fudenberg HH Transfer Factor: Past, present, and future. In: Leukocyte Dialysates and Transfer Factor: Biological Studies and Clinical Investigations. Mayer V, Borvak J, Eds. Institute of Virology, Slovak Academy of Sciences, Bratislava.-1987. 37.. Morescat Laboratory assays for TF. A critical overview. In: Leukocyte Dialysates and Transfer Factor: Biological Studies and Clinical Investigations. Mayer V, Borvak J, Eds. Institute of Virology, Slovak Academy of Sciences, Bratislava.-1987. 38.. Kirkpatrick CH Transfer factor: perspectives in human and veterinary medicine. J Exp Pathol-1987. 3(4);383-98 39.. Spitler LE, Miller L Clinical trials of transfer factor in malignancy. J Exp Pathol-1987. 3(4);549-64 40.. Solinger AM Indications for immunotherapy. Pharmacotherapy-1987. 7(2);S12-20 41.. Pekarek J, Cech K [Transfer factor SEVAC - Perspectives of its medical application.] Zpravy SEVAC-1986. 1;3-36 42.. Fan ZQ The immunity-regulating agent: Transfer factor. Conferernce for Appraisal of Transfer Factor-1985. 43.. Drews J The experimental and clinical use of immune-modulating drugs in the prophylaxis and treatment of infections. Infection-1985. 13 Suppl 2(0);S241-50 44.. Fudenberg HH "Transfer factor": an update. Proc Soc Exp Biol Med-1985. 178(3);327-32 45.. Gershon AA Symposium on infectious complications of neoplastic disease (Part II). Immunoprophylaxis of varicella-zoster infections. Am J Med-1984. 76(4);672-7 46.. Kirkpatrick CH Host factors in defense against fungal infections. Am J Med-1984. 77(4D);1-12 47.. Drews J The experimental and clinical use of immune-modulating drugs in the prophylaxis and treatment of infections. Infection-1984. 12(2);157-66 48.. Wilson GB, Fudenberg HH Is controversy about "transfer factor therapy" nearing an end? Immunol Today-1983. 4(6);157 49.. Chase MW The immunological enigma of transfer factor. In: Immunobiology of Transfer Factor. Kirckpatrick CH, Burger DR, Lawrence HS, Eds. Academic Press, NY-1983.

www.Stylo4Life.com

www.Stylo4Life.com

www.Stylo4Life.com

LOS FACTORES DE TRANSFERENCIA SON IMPORTANTES DESDE EL NACIMIENTO EN LOS SERES VIVOS LOS FACTORES DE TRANSFERENCIA SON IDÉNTICOS EN TODOS LOS ANIMALES CON SISTEMA INMUNOLÓGICO www.Stylo4Life.com

Factor de Transferencia 4Life Research A islados de calostro y de la yema de huevo I nmumoduladores celulares M ovilizadores de células NK P otenciados con fitonutrientes I nteligencia, rapidez y eficacia inmunitaria D irigidos a otros Sistemas www.Stylo4Life.com

www.Stylo4Life.com

www.Stylo4Life.com

1.- Primeros en lanzar al mercado los factores de transferencia con éxito. 2.- Primeros para identificar, aislar y extraer los factores de transferencia de fuentes. 3.- Primeros para combinar los factores de transferencia de huevos y calostro bovino. 4.- Primeros en potenciar los factores de transferencia con fitonutrientes www.Stylo4Life.com

www.Stylo4Life.com

www.Stylo4Life.com

www.Stylo4Life.com

www.Stylo4Life.com

www.Stylo4Life.com

Mantenimiento del Sistema Inmunitario Respaldo Inmunitario: Enfermedades AutoInmune Alergias Enfermedades Infecciosas Tumores - Cáncer www.Stylo4Life.com

www.Stylo4Life.com

www.Stylo4Life.com

www.Stylo4Life.com

Planes de Prevención y Coadyuvantes en El Tratamiento de Enfermedades y Antienvejecimiento www.Stylo4Life.com

PLAN SALUD, BIENESTAR Y ANTIENVEJECIMIENTO INMUNOLÓGICO www.Stylo4Life.com

TF RenewAll TF Plus Inmunomodulador – Lípidos Sangre Protector y Regulador Piel www.Stylo4Life.com

PLAN SALUD Y BIENESTAR CARDIOVASCULAR www.Stylo4Life.com

TF Cardio Inmunomodulador – Lípidos Sangre Protector y Regulador Cardiovascular Protector Vasos Sanguíneos Defensa Ocular Control Peso Metabolico www.Stylo4Life.com

PLAN SALUD Y BIENESTAR ENDOCRINO www.Stylo4Life.com

TF Glucoach Inmunomodulador – Lípidos Sangre Azucar Sangre Protector Endocrino Diabetes 1 y 2 Control Peso Metabolico y Endocrino www.Stylo4Life.com

PLAN SALUD Y BIENESTAR SISTEMA NERVIOSO www.Stylo4Life.com

TF Recall Inmunomodulador – Neuroprotector Activador Metabólico y Cerebral Cognición y Memoria Stress, Depresión y Crisis de Pánico www.Stylo4Life.com

PLAN SALUD Y BIENESTAR BUCAL www.Stylo4Life.com

TF Spray TF Toothpaste www.Stylo4Life.com

PLAN SALUD Y BIENESTAR INFANTIL, MASCULINO Y FEMENINO www.Stylo4Life.com

TF Kids 2 Inmunomodulador Nutrición Regulador Endocrino www.Stylo4Life.com

TF MalePro Inmunomodulador Protector Cardiovascular Prostático Regulador Hormonal Regulador Masculino www.Stylo4Life.com

TF Belle Vie Inmunomodulador Protector Cardiovascular Mamario y Reproductor Regulador Hormonal Regulador Femenino www.Stylo4Life.com

1.- No son Fármacos sino Productos de Salud Natural. 2.- Productos de Prevención. 3.- Complementan un Tratamiento. 4.- Recomendados por TODOS y a TODOS www.Stylo4Life.com

Móvil: 591 70292077 y 72128500 José Luís Vega Galarza E-mail: Stylo4Life@Gmail.com www.Stylo4Life.com S alud – B ienestar – N utrición - A ntienvejecimiento